Acute kidney failure. Acute kidney failure
Conditions
Interventions
Intervention 1: This group will receive an intramuscular dose of placebo (1 mililiter of isotonic NACL 0.9% manufactured by Shahid Ghazi Pharmaceutical company, Tabriz, Iran) during the first 24 hours
Sponsors
Ahvaz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Traumatic patient Age more than 18 Hospitalized in intensive care unit more than 24 hours Revised trauma score (RTS) >=6 New trauma score (NTS) >=8
Exclusion criteria
Exclusion criteria: Chronic renal failure Cancer Autoimione disease Abstinece of patient
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Creatinin. Timepoint: Before intervention and daily till discharge from ICU (maximum 28 days). Method of measurement: biochemical auto-analyser. | — |
Secondary
| Measure | Time frame |
|---|---|
| Blood urea nitrogen. Timepoint: Before intervention and daily till 28 days or discharge time. Method of measurement: Biochemical auto-analyser.;Body mass index. Timepoint: Before intervention and 28th day or at discharge time. Method of measurement: Based on the result of dividing weight in kilograms by height in meters.;Abdominal circumference. Timepoint: Before intervention and 28th day or at discharge time. Method of measurement: Mesurment with a meter.;Mortality. Timepoint: After 28 days or at discharge time. Method of measurement: Alive or dead.;Ventilator free days (in first 28 days). Timepoint: After 28 days or at discharge time. Method of measurement: The number of days of the first 28 days that the patient was not connected to the ventilator. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMosen savaie
Ahvaz University of Medical Sciences
Outcome results
None listed